PRICE T ROWE ASSOCIATES INC /MD/ - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 231 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$186
-99.9%
209,418
+8.4%
0.00%
Q3 2022$304,000
+6.7%
193,237
+36.5%
0.00%
Q2 2022$285,000
-6.6%
141,561
+8.3%
0.00%
Q1 2022$305,000
-41.3%
130,715
+16.8%
0.00%
Q4 2021$520,000
-33.2%
111,906
+9.7%
0.00%
Q3 2021$778,000
-35.5%
101,973
-18.1%
0.00%
Q2 2021$1,206,000
+31.9%
124,473
+12.7%
0.00%
Q1 2021$914,000
+13.1%
110,484
-6.7%
0.00%
Q4 2020$808,000
-36.5%
118,375
+3.7%
0.00%
Q3 2020$1,273,000
+179.2%
114,153
+57.4%
0.00%
Q2 2020$456,000
+225.7%
72,546
-4.8%
0.00%
Q1 2020$140,000
-6.0%
76,189
+72.4%
0.00%
Q4 2019$149,000
+77.4%
44,189
+12.4%
0.00%
Q3 2019$84,000
-17.6%
39,325
+2.5%
0.00%
Q2 2019$102,000
+61.9%
38,372
+191.3%
0.00%
Q1 2019$63,000
+103.2%
13,172
+3.1%
0.00%
Q4 2018$31,000
-90.4%
12,772
-82.6%
0.00%
Q3 2018$322,000
-8.0%
73,226
+50.8%
0.00%
Q2 2018$350,000
+52.2%
48,573
+8.7%
0.00%
Q1 2018$230,000
-21.8%
44,696
-42.2%
0.00%
Q4 2017$294,000
+14.8%
77,300
+153.8%
0.00%
Q3 2015$256,00030,4620.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 5,216,250$4,621,5981.04%
B. Riley Securities, Inc. 5,216,250$4,621,5981.00%
EMFO, LLC 209,398$185,5270.19%
Wellspring Financial Advisors, LLC 483,551$428,4260.14%
Mayo Clinic 300,000$267,0000.14%
swisspartners Ltd. 110,000$97,4650.12%
Donald L. Hagan, LLC 169,514$150,1890.09%
Oaktree Fund Advisors, LLC 66,000$58,4760.09%
EUDAIMONIA ADVISORS LLC 138,887$123,0540.08%
Asset Management Resources, LLC 138,020$122,2860.08%
View complete list of SORRENTO THERAPEUTICS INC shareholders